Cell Theranostics ‘s 3 chelator platforms are ideal for developing theranostic agents to diagnose and treat cancer and other diseases.
Theranostic medicine is a major step forward in making personalized medicine a reality. At Cell Theranostics, our vision is the combination of target specific diagnostic imaging and compatible target specific therapy at the molecular level. Each Cell Theranostics diagnostic imaging compound and its companion therapeutic compound share the same target specific core. The clinical objective is to diagnose and stage the disease, determine the proper therapeutic dose level for the individual patient, treat the patient and follow-up by imaging the patient’s response to the therapy while the patient is undergoing the therapy.